A Scholar Studies How Digital Health Can Deliver on Its Promise - Columbia University Mailman School of Public Health
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Technology promises to improve health care delivery, enhance disease management, and promote satisfaction for patients and providers alike. Yet the reality often falls short. Mitchell Tang, an assistant professor of Health Policy and Management, studies how digital health technologies function in the real world, uncovering subtle challenges they can introduce and identifying potential solutions.
His latest study, published in JAMA Network Open, analyzed 3.6 million patient portal messages from patients to their health care teams to find clues about why people from historically marginalized groups are less likely to receive a response from their doctors. Tang and his coauthors found that writing style accounted for a substantial share of these disparities.
This article is an excerpt. To read the full content, visit the original source. Columbia University Mailman School of Public Health
Related articles
Meet Dr. Sonia Anand, 2026-27 Scholar-in-Residence at Unity Health Toronto - Unity Health Toronto
Meet Dr. Sonia Anand, 2026-27 Scholar-in-Residence at
Academic freedom in danger, scholar cautions
There is an increasing disparity between university’s academic freedom statements and its actions. These comments were made during a talk held October 8 titled “Strengthening academic freedom in the corporatized university” by James Turk. A researcher on academic freedom, Turk is the director of the Centre for Free Expression at Toronto Metropolitan University. Previously, he was executive director of the Canadian Association of University Teachers (CAUT) from 1998 to 2014.
Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
0 comments
No comments yet. Be the first to share your thoughts!